Advanced search
Publication Cover
Free Radical Research Volume 36, 2002 - Issue 7
Submit an article Journal homepage
27
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Effects of Oxicam Inhibitors of Cyclooxygenase on Oxidative Stress Generation in Rat Gastric Mucosa. A Comparative Study

I. Villegas Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street, 41012 Seville, Spain
,
M.J. Martín Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street, 41012 Seville, Spain
,
C. La Casa Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street, 41012 Seville, Spain
,
V. Motilva Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street, 41012 Seville, Spain
&
C. Alarcón De La Lastra Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street, 41012 Seville, Spain
Pages 769-777 | Published online: 07 Jul 2009

  • Simon, L.S. (1998) "Biology and toxic effects of nonsteroidal anti-inflammatory drugs", Curr. Opin. Rheumatol. 10, 153-158.
  • Vane, J.R. and Sotting, R.M. (1998) "Mechanism of action of nonsteroidal anti-inflammatory drugs", Am. J. Med. 104, 2S-8S.
  • Warner, T.D., Giuliano, F., Vojnovic, I., Bukada, A., Mitchell, J.A. and Vane, J.R. (1999) "Non-steroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis", Prac. Natl Acad. Sci. USA 96(13), 7563-7568.
  • Cryer, B. and Feldman, M. (1998) "Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs", Am. J. Med. 104(5), 413-421.
  • Hawkey, C.J. (1999) "Cox-2 inhibitors", Lancet 353, 307-314.
  • Riendeau, D., Charleson, S., Cromlish, W., Mancini, J.A., Wong, E. and Guay, J. (1997) "Comparison of the cyclooxygenase (COX)-I inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays", Can. J. Physiol. Pharmacol. 75, 1088-1095.
  • Feldman, M. and McMahon, A.T. (2000) "Do cyclooxygenase2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?", Ann. Intern. Med. 132, 134-143.
  • Wallace, J.L. (1997) "Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years", Gastroenterology 112, 1000-1016.
  • Yoshikawa, T. and Naito, Y. (2000) "The role of neutrophils and inflammation in gastric mucosal injury", Free Radie. Res. 33(6), 785-794.
  • Rothlein, R., Czajkowski, M. and Kishimoto, T.K. (1991) "Intercellular adhesion molecule-1 in inflammatory response", Chem. Immunol. 50, 135-142.
  • Santucci, L., Fiorucci, S., Giansanti, M., Brunori, P.M., Di Matteo, F.M. and Morelli, A. (1995) "Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha", Gut 35, 909-915.
  • Morzycki, W., Sadowska, J. and Issekutz, A.C. (1990) "Interleukin-1 and tumor necrosis factor-a induced polymorphonuclear leukocyte-endothelial cell adhesion and transendothelial migration in vitro: the effect of apical versus basal monolayer stimulation", Immunol. Lett. 25, 331-340.
  • Appleyard, C.B., McCafferty, D.M., Tigley, A.W., Swan, M.G. and Wallace, J.L. (1996) "Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence", Am. J. Physiol. 270(33), G42-G48.
  • McCarthy, D.M. (1995) "Mechanisms of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs", Scand. J. Gastroenterol. 30(Suppl. 208), 24-29.
  • Naito, Y, Yoshikawa, T., Yoshida, N. and Kondo, M. (1998) "Role of oxygen radical and lipid peroxidation in indomethacin-induced gastric mucosal injury", Dig. Dis. Sci. 43(Suppl. 9), 30S-34S.
  • Jiménez, M.D., Martin, M.J., Pozo, D., Alarcon de la Lastra, C., Esteban, J., Bruseghini, L., Esteras, A. and Motilva, V. (2001) "Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins", Dig. Dis. Sci., 47, 44-53.
  • Sânchez, S., Martin, M.J., Ortiz, P., Motilva, V. and Alarcon de la Lastra, C. (2002) "Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa. Comparison with acetaminophen and diclofenac", Dig. Dis. Sci., In press.
  • Yoshikawa, T., Naito, Y, Kishi, A., Tomii, T., Kaneko, T., Linuma, S., Ichikawa, H., Yasuda, M., Takahashi, S. and Kondo, M. (1993) "Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats", Gut 34, 732-737.
  • Tanaka, J. and Yuda, Y (1996) "Lipid peroxidation in gastric mucosal lesions induced by indomethacin in rat", Biol. Pharm. Bull. 19, 716-720.
  • Smith, W.L., Meade, E.A. and DeWitt, D.L. (1994) "Interactions of PGH synthase isozymes-1 and -2 with NSAID", Ann. N.Y. Acad. Sci. 744, 50-57.
  • Cryer, B. and Dubois, A. (1998) "The advent of highly selective inhibitors of cyclooxygenase-a review", Prostaglandins Other Lipid Mediat. 56(5-6), 341-361.
  • Barner, A. (1996) "Review of clinical trials and benefit/risk ratio of meloxicam", Scand. J. Rheumatol. 25(Suppl. 102), 29-37.
  • Avila, J.R., Alarcon de la Lastra, C., Martin, M.J., Motilva, V, Luque, I., Delgado, D., Esteban, J. and Herrerias, J. (1996) "Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats", Inflamm. Res. 45(2), 83-88.
  • Villegas, I., Martin, M.J., La Casa, C., Motilva, V. and Alarcon de la Lastra, C. (2000) "Effects of meloxicam on oxygen radical generation in rat gastric mucosa", Inflamm. Res. 49(7), 361-366.
  • Villegas, I., Alarcon de la Lastra, C., La Casa, C. and Motilva, V. (2001) "Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats", Eur. J. Pharmacol. 414(1), 79-86.
  • Martin, M.J., Jiménez, M.D., Alarcon de la Lastra, C., La Casa, C., Herrerias, J.M., Bruseghini, L., Esteras, A. and Motilva, V. (1997) "Protective effect of L-arginine against ibuprofeninduced gastric injury in rats", Pharm. Sci. 3, 609-612.
  • Grisham, M.B., Beniot, J.N. and Granger, D.N. (1990) "Assessment of leucocyte in involvement during ischemia and reperfusion on the intestine", In: Packer, L. and Glazer, A.E., eds, Methods in Enzymology. Oxygen Radicals in Biological Systems (Academic Press, San Diego), pp. 729-741.
  • Devenyi, Z.J., Orcharf, J.L. and Powers, R.E. (1987) "Xanthine oxidase activity in mouse pancreas: effects of caeruleininduced acute pancreatitis", Biochem. Biophys. Res. Commun. 149, 841-845.
  • McCord, C.P. and Fridovich, I. (1969) "Superoxide dismutase", J. Biol. Chem. 244(22), 6049-6055.
  • Lawrence, R.A. and Burk, R.F. (1976) "Glutathione peroxidase activity in selenium deficient al liver", Biochem. Biophys. Res. Commun. 71, 952-958.
  • Worthington, D.J. and Rosemeyer, M.Y. (1974) "Human glutathione reductase: purification of the crystalline enzyme from erythrocytes", Eur. J. Biochem. 48, 167-177.
  • Anderson, M.E. (1985) "Determination of glutathione and glutathione disulfide in biological samples", Methods Enzymol. 113, 548-555.
  • Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akamatsu, T. and Kasuga, M. (1997) "Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice", Gastroenterology 112, 387-397.
  • Ukawa, H., Yamakuni, H., Kato, S. and Takeuchi, K. (1998) "Effects of cyclooxygenase-2 selective and nitric-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach", Dig. Dis. Sci. 43, 2003-2011.
  • Schmassmann, A., Peskar, B.M., Stettier, C., Netzer, R, Stroff, T., Flogerzi, B. and Halter, F. (1998) "Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastrointestinal ulcer models in rats", Br. J. Pharmacol. 123(5), 795-804.
  • Reuter, B.K., Asfaha, S., Buret, A., Sharkey, K.A. and Wallace, J.L. (1996) "Exacerbation of inflammation-associated colonie injury in rat through inhibition of cyclooxygenase-2", J. Clin. Investig. 98, 2076-2085.
  • Engelhardt, G., Bögel, R., Schnitzler, C.H.R. and Utzmann, R. (1996) "Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings", Biochem. Pharmacol. 51, 29-38.
  • Ogino, K., Hatanaka, K., Kawamura, M., Ohno, T. and Harada, Y. (2000) "Meloxicam inhibits prostaglandin E2 generation via cyclooxygenase 2 in the inflammatory site but not via cyclooxygenase 1 in the stomach", Pharmacology 61, 244-250.
  • Tegeder, I., Neupert, W., Guhring, H. and Geisslinger, G. (2000) "Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs", J. Pharmacol. Exp. Ther. 292(3), 1161-1168.
  • Hawkey, CJ. and Nottingham, G.I. (1997) "Trials Service for the International SELECT Study Group. Low gastrointestinal toxicity of meloxicam, a preferential inhibitor of the inducible cyclooxygenase (COX-2) enzyme compared to piroxicam [abstract]", Gut 41 (Suppl. 3), A7.
  • Dequeker, J., Hawkey, C., Kahan, A., Steinbrück, K., Alegre, C., Baumelou, E., Begaud, B., Isomäki, H., Littlejohn, G., Mau, J. and Papazoglou, S. (1998) "Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-Scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis", Br. J. Rheumatol. 37(9), 946-951.
  • Laudanno, O.M., Cesolari, J.A., Esnarriaga, J., Rista, L., Piombo, G., Maglione, C.B., Aramberry, L., Sambrano, J., Godoy, A. and Rocaspana, A. (2001) "Gastrointestinal damage induced by celecoxib and rofecoxib in rats", Dig. Dis. Sci. 46(4), 779-784.
  • Komhoff, M., Wang, J.L., Cheng, H.F., Langenbach, R., McKanna, J.A., Harris, R.C. and Breyer, M.D. (2000) "Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development", Kidney Int. 57(2), 414-422.
  • Vogiagis, D., Glare, E.M., Misajon, A., Brown, W and O'Brien, P.E. (2000) "Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers", Am. J. Physiol. 278(5), G820-G827.
  • McKanna, J.A., Zhang, M.Z., Wang, J.L., Cheng, H. and Harris, R.C. (1998) "Constitutive expression of cyclooxygenase-2 in rat vas deferens", Am. J. Physiol. 275, R227-R233.
  • Lim, H., Paria, B.C., Das, S.K., Dinchuk, J.E., Langenbach, R., Trzaskos, J.M. and Dey, S.K. (1997) "Multiple female reproductive failures in cyclooxygenase 2-deficient mice", Cell 91, 197-208.
  • Vanegas, H. and Schaible, H.G. (2001) "Prostaglandins and cyclooxygenases in the spinal cord", Prog. Neurobiol. 64(4), 327-363.
  • Halliday, G., Robinson, S.R., Shepherd, C. and Kril, J. (2000) "Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms", CHn. Exp. Pharmacol. Physiol. 27(1-2), 1-8.
  • Gretzer, B., Ehrlich, K., Maricic, N., Lambrecht, N., Respondek, M. and Peskar, B.M. (1998) "Selective cyclooxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach", Br. J. Pharmacol. 123, 927-935.
  • Wallace, J.L., McKnight, W., Reuter, B.K. and Vergnolle, N. (2000) "NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2", Gastroenterology 119(3), 706-714.
  • Shigeta, J., Takahashi, S. and Okabe, S. (1998) "Role of cyclooxygenase-2 in the healing of gastric ulcers in rats", J. Pharmacol. Exp. Ther. 286(3), 1383-1390.
  • Halter, E, Tarnawski, A.S., Schmassman, A. and Peskar, B.M. (2001) "Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives", Gut 49(3), 443-453.
  • Jones, M.K., Wang, H., Peskar, B.M., Levin, E., Itani, R.M., Sarfeh, I.J. and Tarnawski, A.S. (1999) "Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing", Nat. Med. 5, 1418-1423.
  • Tanaka, A., Araki, H., Komoike, Y, Hase, S. and Takeuchi, K. (2001) "Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs", J. Physiol, Paris 95(1-6), 21-27.
  • Wallace, J.L. (1999) "Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs", Am. J. Med. 107, 11S-16S.
  • Mauprivez, C., Bertrand, V. and Guimbaud, R. (1997) "Up-regulation of tissular TNF-cx in inflammatory rats by NSAID: potential therapeutic and toxicological implication", Fundam. Clin. Pharmacol. 11, 183.
  • Naito, Y, Yoshikawa, T., Kaneko, T., Linuma, S., Nishimura, S., Takahashi, S. and Kondo, M. (1993) "Role of oxygen radicals in indomethacin-induced gastric mucosal microvascular injury in rats", J. Clin. Gastroenterol. 17, S99-S103.
  • Hutt, A.J. and Caldwell, J. (1984) "The importance of streochemistry in the clinical pharmacokinetics of the 2-arylpropionic acid non-steroidal anti-inflammatory drugs", Clin. Pharmacokinet. 9, 371-373.
  • Konturek, P.C., Brzozowski, T, Pierzchlski, P., Swiecien, S., Pajdo, R., Hahn, E.G. and Konturek, S.J. (1998) "Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclo-oxygenase COX-1 and COX-2 during gastric adaptation to aspirin damage in rats", Aliment. Pharmacol. Ther. 12, 767-777.
  • Alarcon de la Lastra, C., Nieto, A., Motilva, V, Martin, M.J., Herrerias, J.M., Cabré, F. and Mauleon, D. (2000) "Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress", Inflamm. Res. 49, 627-632.
  • Van der Vliet, A. and Bast, A. (1991) "Role of reactive oxygen species in intestinal diseases", Free Radic. Biol. Med. 12, 499-513.
  • Alarcon de la Lastra, C., Lopez, A., Martin, M.J., La Casa, C. and Motilva, V. (1997) "Cinitapride protects against ethanol-induced gastric mucosal damage: Role of 5-hydroxytryptamine, prostaglandins and sulphydryl compounds", Pharmacology 54, 193-202.
  • Halliwell, B.J. and Gutteridge, J.M.C. (1989) Free Radicals in Biology and Medicine (Clarendon Press, Oxford).
  • Alarcon de la Lastra, C., Motilva, V, Martin, M.J., Nieto, A., Barranco, M.D., Cabeza, J. and Herrerias, J.M. (1999) "Protective effect of melatonin on indomethacin-induced gastric injury in rats", J. Pineal Res. 26(2), 101-107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.